For deeper understanding of Siah2 role in ICC tumor immune microenvironment, we used CD34+ humanized NCG mice models, which have the same composition of immune cell subsets, especially regarding myeloid cells, which are considered to be a better preclinical model (33, 34). The gene discussed is SIAH2; the disease is intrahepatic cholangiocarcinoma.